<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/39193/ino-5401-and-ino-9012-in-combination-with-cemiplimab-regn2810---will-this-data-effect-clinicians-today---david-a.-reardon-md-dana-farber-cancer-institute-danafarber-glioblastoma?channelName=Cancer-News" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma

0:02:07

INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma

User Photo

Cancer-News

5 months

89 Views

Share Report Add to 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/39193/ino-5401-and-ino-9012-in-combination-with-cemiplimab-regn2810---will-this-data-effect-clinicians-today---david-a.-reardon-md-dana-farber-cancer-institute-danafarber-glioblastoma?channelName=Cancer-News" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://www.oncologytube.com/videoEmbed/39193/ino-5401-and-ino-9012-in-combination-with-cemiplimab-regn2810---will-this-data-effect-clinicians-today---david-a.-reardon-md-dana-farber-cancer-institute-danafarber-glioblastoma?channelName=Cancer-News"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://www.oncologytube.com/videoEmbed/39193/ino-5401-and-ino-9012-in-combination-with-cemiplimab-regn2810---will-this-data-effect-clinicians-today---david-a.-reardon-md-dana-farber-cancer-institute-danafarber-glioblastoma?channelName=Cancer-News" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://www.oncologytube.com/v/39193?channelName=Cancer-News"><img src="https://www.oncologytube.com/videos/_YPTuniqid_5f31ca7da70380.47379100.jpg?1597098627">INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma</a>

Link (BBCode):

[url=https://www.oncologytube.com/v/39193?channelName=Cancer-News][img]https://www.oncologytube.com/videos/_YPTuniqid_5f31ca7da70380.47379100.jpg?1597098627[/img]INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Description:

David A. Reardon, MD Dana-Farber Cancer Institute discusses INO-5401 and INO-9012 in combination with cemiplimab REGN2810 in newly diagnosed glioblastoma GBM Interim results. - How will this affect clinicians today?

Up Next Autoplay

>